Ocular Therapeutix Inc (OCUL)

Cost of Revenue

$2.01M

Quarterly · Period ending: · USD

OCUL logo

OCUL Cost of Revenue

Latest reported$2.01M
OCUL Quarterly Cost of Revenue ($0.00 → $2.01M)
High-resolution chart · PNG

OCUL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ocular Therapeutix Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,011,000
1,329,000
1,594,000
1,774,000
1,944,000
1,262,000
1,230,000
1,561,000
1,509,000
1,326,000
1,386,000
1,377,000
1,304,000
1,214,000
1,012,000
1,073,000
1,155,000
1,300,000
1,108,000
1,310,000
1,096,000
892,000
680,000
450,000
134,000
819,000
839,000
806,000
552,000
128,000
117,000
115,000
153,000
80,000
113,000
125,000
104,000
115,000
127,000
112,000
105,000
99,000
92,000
91,000
80,000
56,000
30,000
32,000
20,000
9,000
10,517,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.